Fengwei Zou

Title: Fengwei Zou: Innovator in Nitric Oxide Synthase Inhibition

Introduction

Fengwei Zou is a notable inventor based in Evanston, IL (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that inhibit nitric oxide synthases (NOSs). His work has implications for treating various diseases associated with NOS activity.

Latest Patents

Fengwei Zou holds a patent for "Mammalian and bacterial nitric oxide synthase inhibitors." This patent discloses compounds that effectively inhibit the biological activity of nitric oxide synthases. Additionally, it includes pharmaceutical compositions comprising these compounds and methods for their use in treating subjects in need. The disclosed compounds may be utilized in methods for treating individuals who have or are at risk of developing diseases linked to NOS activity.

Career Highlights

Fengwei Zou is affiliated with Northwestern University, where he conducts his research and development work. His innovative approach to pharmacology has led to advancements in therapeutic options for various health conditions.

Collaborations

Fengwei Zou has collaborated with esteemed colleagues, including Richard B Silverman and Heng-Yen Wang. Their combined expertise enhances the research and development efforts in the field of nitric oxide synthase inhibitors.

Conclusion

Fengwei Zou's contributions to the field of nitric oxide synthase inhibition represent a significant advancement in pharmacological research. His innovative compounds and methods hold promise for improving treatment options for patients with related health issues.